Tear Fluid Biomarkers and Quality of Life in People with Type 2 Diabetes and Dry Eye Disease
Dry eye disease (DED) can be extremely distressing and is common in type 2 diabetes (T2D). To investigate potential biomarkers of DED in T2D, panels of proteins in tears, alongside clinical signs and symptoms of DED, were assessed. Patients were classified into four groups: T2D + DED (<i>n<...
Main Authors: | Mungunshur Byambajav, Andrew Collier, Xinhua Shu, Suzanne Hagan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/6/733 |
Similar Items
-
Dry Eye Disease and Tear Cytokine Levels—A Meta-Analysis
by: Matilde Roda, et al.
Published: (2020-04-01) -
Tear biomarkers in dry eye disease: Progress in the last decade
by: Nimisha R Kumar, et al.
Published: (2023-01-01) -
Clinical observation of cyclosporine eye drops with artificial tears for dry eyes
by: Xue-Bing Yang, et al.
Published: (2016-05-01) -
Patient stratification using point of care biomarkers in dry eye disease
by: Rohit Shetty, et al.
Published: (2023-01-01) -
Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease
by: Marc Labetoulle, et al.
Published: (2022-02-01)